Performance metrics and trade details for IONS breakout.
Ionis Pharmaceuticals turned profitable for the first time with 256% YoY earnings growth, 101% revenue growth, and massive surprises: +868% EPS and +52% revenue.
The stock gapped up 7.4% on the news but couldn’t hold momentum—entering via a 1-min ORB and using the day’s low as a stop would’ve resulted in a modest 1.3% loss.